RO7496353
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RO7496353, covering 2026-02-02 to 2026-02-02. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate Safety, Pharmacokinetics, & Activity of RO7496353 in Combination With a Checkpoint Inhibitor With or Without Standard-of-care Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors; Urothelial Carcinoma Substudy in Association With RO7496353 Study GO44010 [Phase 1]